1. |
Jemal A, Bray F, Center MM, et al.Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
|
2. |
Jemal A, Siegel R, Ward E, et al.Cancer statistics[J].CA Cancer J Clin, 2008, 58(2):71-96.
|
3. |
Wheelock MJ, Johnson KR.Cadherins as modulators of cellular phenotype[J].Annu Rev Cell Dev Biol, 2003, 19:207-235.
|
4. |
Chaffer CL, Weinberg RA.A perspective on cancer cell metastasis[J].Science, 2011, 331(6024):1559-1564.
|
5. |
Wakamatsu Y, Sakamoto N, Oo HZ, et al.Expression of cancer stem cell markers ALDH1, CD44, CD133 in primary tumor and lymph node metastasis of gastric cancer[J].Pathol Int, 2012, 62(2):112-119.
|
6. |
Rocco A, Liguori E, Pirozzi G, et al.CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors[J].J Cell Physiol, 2012, 227(6):2686-2693.
|
7. |
Shi C, Tian R, Wang M, et al.CD44+CD133+ population exhi-bits cancer stem cell-like characteristics in human gallbladder carc-inoma[J].Cancer Biol Ther, 2010, 10(11):1182-1190.
|
8. |
Japanese Gastric Cancer Association.Japanese Classification of Gastric Carcinoma-2nd English Edition[J].Gastric Cancer, 1998, 1(1):10-24.
|
9. |
Magee JA, Piskounova E, Morrison SJ.Cancer stem cells:impact, heterogeneity, and uncertainty[J].Cancer Cell, 2012, 21(3):283-296.
|
10. |
Bonnet D, Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J].Nat Med, 1997, 3(7):730-737.
|
11. |
Mizrak D, Brittan M, Alison MR.CD133:molecule of the moment[J].J Pathol, 2008, 214(1):3-9.
|
12. |
Rajarajan A, Stokes A, Bloor BK, et al.CD44 expression in oro-pharyngeal carcinoma tissues and cell lines[J].PLoS One, 2012, 7(1):e28776.
|
13. |
Knutson KL, Lu H, Stone B, et al.Immunoediting of cancers may lead to epithelial to mesenchymal transition[J].J Immunol, 2006, 177(3):1526-1533.
|
14. |
Du L, Wang H, He L, et al.CD44 is of functional importance for colorectal cancer stem cells[J].Clin Cancer Res, 2008, 14(21):6751-6760.
|
15. |
Haraguchi N, Ohkuma M, Sakashita H, et al.CD133+CD44+ population efficiently enriches colon cancer initiating cells[J].Ann Surg Oncol, 2008, 15(10):2927-2933.
|
16. |
Huang X, Sheng Y, Guan M.Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis[J].Surg Oncol, 2012, 21(2):103-107.
|
17. |
Ponta H, Sherman L, Herrlich PA.CD44:from adhesion molecules to signalling regulators[J].Nat Rev Mol Cell Biol, 2003, 4(1):33-45.
|
18. |
Ishimoto T, Oshima H, Oshima M, et al.CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis[J].Cancer Sci, 2010, 101(3):673-678.
|
19. |
姜海广, 陆瑞祺, 姜波键, 等.基质细胞源性因子-1α/CXC趋化因子受体-4轴经PI3K/Akt通路对胃癌细胞CD133表达的调控作用[J].中华实验外科杂志, 2012, 29(3):378-380.
|
20. |
Chen S, Hou JH, Feng XY, et al.Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma[J].J Surg Oncol, 2013, 107(8):799-806.
|
21. |
Dalerba P, Dylla SJ, Park IK, et al.Phenotypic characterization of human colorectal cancer stem cells[J].Proc Natl Acad Sci U S A, 2007, 104(24):10158-10163.
|
22. |
Ginestier C, Hur MH, Charafe-Jauffret E, et al.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J].Cell Stem Cell, 2007, 1(5):555-567.
|
23. |
Kojima M, Ishii G, Atsumi N, et al.Immunohistochemical dete-ction of CD133 expression in colorectal cancer:a clinicopatholo-gical study[J].Cancer Sci, 2008, 99(8):1578-1583.
|
24. |
Shimada Y, Ishii G, Nagai K, et al.Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung[J].Cancer Sci, 2009, 100(11):2054-2059.
|
25. |
Charafe-Jauffret E, Ginestier C, Iovino F, et al.Aldehyde dehy-drogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer[J].Clin Cancer Res, 2010, 16(1):45-55.
|